The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.
This illustrative example from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.
The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.
Whoever's closest to the consumer will be the gatekeeper of the industry.
New models of primary care are emerging. Here's how to make sense of the shifting landscape.
Pharmaceutical companies are uniquely positioned to impact health equity. It must become a corporate priority and engrained in the product life cycle.
As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.